Short-term, high-dose prednisolone doesn’t raise diabetes risk in RA patients – SmartBrief

Short-term treatment with 60 mg or 30 mg per day of prednisolone, a type of corticosteroid, did not appear to lower glucose tolerance in rheumatoid arthritis patients, including those with impaired glucose metabolism or type 2 diabetes. The study in …